Market capitalization is the total value the stock market puts on a company: its share price multiplied by the number of shares outstanding. Each point here is the share count reported in a filing multiplied by the closing price on that filing date, adjusted for later stock splits, so the history moves when a new filing arrives rather than with each day's trading. A larger market cap means investors collectively value the company more highly; by itself it says nothing about profit or debt. Annual points keep the latest observation in each calendar year.
Structure Therapeutics Inc. market cap for the quarter ending 2026-07-31 was $10.27B, a 234.19% increase year-over-year.
Structure Therapeutics Inc. market cap for the quarter ending 2026-06-30 was $11.48B, a 219.53% increase year-over-year.
Structure Therapeutics Inc. market cap for the quarter ending 2026-04-30 was $8.83B, a 89.50% increase year-over-year.
Structure Therapeutics Inc. market cap for the quarter ending 2026-03-31 was $10.29B, a 244.23% increase year-over-year.
Structure Therapeutics Inc. market cap for fiscal 2026 was $10.27B.
Structure Therapeutics Inc. market cap for fiscal 2025 was $14.78B, a 217.21% increase from fiscal 2024.
Structure Therapeutics Inc. market cap for fiscal 2024 was $4.66B, a 17.86% decline from fiscal 2023.
Structure Therapeutics Inc. market cap for fiscal 2023 was $5.67B.